1,278
Total Claims
$1.4M
Drug Cost
502
Beneficiaries
$2,861
Cost/Patient
Peer Comparison vs. 13,195 Dermatology providers
+137%
Cost per patient vs peers
$2,861 vs $1,209 avg
+51%
Brand preference vs peers
11.3% vs 7.5% avg
Brand vs Generic
89% generic
Brand: 145 claims · $1.4M
Generic: 1,133 claims · $50K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Risankizumab-Rzaa | 22 | $452K |
| Adalimumab | 26 | $369K |
| Secukinumab | 16 | $164K |
| Dupilumab | 24 | $79K |
| Clobetasol Propionate | 173 | $9,765 |
| Ketoconazole | 106 | $2,673 |
| Methotrexate Sodium | 120 | $2,169 |
| Tacrolimus | 13 | $2,074 |
| Metronidazole | 20 | $1,656 |
| Fluorouracil | 19 | $1,650 |
| Triamcinolone Acetonide | 103 | $1,571 |
| Doxycycline Hyclate | 64 | $1,316 |
| Spironolactone | 26 | $1,048 |
| Fluocinonide | 27 | $1,037 |
| Fluocinolone Acetonide Oil | 15 | $867 |
Prescribing Profile
33
Unique Drugs
Patient Profile
71
Avg Age
63%
Female
1.26
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About